Enhanced PI3K signaling, either through loss of expression of its antagonist PTEN, or through activating mutations in exons 9 and 20 of the PIK3CA gene, encoding the catalytic subunit p110α of PI3K, can be observed in a variety of human malignancies, including colon cancer [13] [14]. This evidence concerns the gene PTEN and colonic neoplasm.